Second primary cancer after female breast cancer: Familial risks and cause of death

With continuous increases in survival rates following breast cancer (BC) diagnosis, the challenge of multiple primary cancers has become an issue. The data on familial risk of SPCs after BC diagnosis and the related mortality in BC patients are scarce.

[1]  H. Storm,et al.  Nordic Cancer Registries – an overview of their procedures and data comparability , 2017, Acta oncologica.

[2]  J. Ludvigsson,et al.  The Swedish cause of death register , 2017, European Journal of Epidemiology.

[3]  H. Frick,et al.  Multiple primary tumours: challenges and approaches, a review , 2017, ESMO Open.

[4]  E. Horwitz,et al.  Causes of death among cancer patients , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Nicholas M. Donin,et al.  Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008 , 2016, Cancer.

[6]  Jan Sundquist,et al.  Patterns of metastasis in colon and rectal cancer , 2016, Scientific Reports.

[7]  L. Holmberg,et al.  Family history of breast cancer and its association with disease severity and mortality , 2016, Cancer medicine.

[8]  J. Raemaekers,et al.  Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. , 2015, The New England journal of medicine.

[9]  H. Brenner,et al.  Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. , 2015, Cancer letters.

[10]  Judy E Garber,et al.  Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  G. Palomaki.  Is it time for BRCA1/2 mutation screening in the general adult population?: impact of population characteristics , 2014, Genetics in Medicine.

[12]  K. Hemminki,et al.  Metastatic sites and survival in lung cancer. , 2014, Lung cancer.

[13]  K. Hemminki,et al.  Multiple primary (even in situ) melanomas in a patient pose significant risk to family members. , 2014, European journal of cancer.

[14]  K. Hemminki,et al.  Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database. , 2014, The Journal of investigative dermatology.

[15]  A. Ng,et al.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors , 2013, Nature Reviews Clinical Oncology.

[16]  M. Golatta,et al.  The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study , 2012, Breast Cancer Research.

[17]  K. Hemminki,et al.  Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry , 2012, International journal of cancer.

[18]  Andrea Ng,et al.  Second malignant neoplasms: assessment and strategies for risk reduction. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Sofia Khan,et al.  Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations , 2012, Familial Cancer.

[20]  K. Hemminki,et al.  Death causes in breast cancer patients. , 2012 .

[21]  R. Westerling,et al.  Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995. , 2009, Journal of clinical epidemiology.

[22]  A. Whittemore,et al.  Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry , 2009, Breast Cancer Research and Treatment.

[23]  S. Kaasa,et al.  Population-based study of dying in hospital in six European countries , 2008, Palliative medicine.

[24]  K. Hemminki,et al.  Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. , 2007, Cancer research.

[25]  K. Hemminki,et al.  Familial risk of cancer shortly after diagnosis of the first familial tumor. , 2005, Journal of the National Cancer Institute.

[26]  O. Olopade,et al.  The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. , 2005, Gynecologic oncology.

[27]  M. Arroyo-Morales,et al.  Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. , 2015, Gynecologic oncology.

[28]  J. Frödin,et al.  Multiple primary malignant tumors in a national cancer registry--reliability of reporting. , 1997, Acta oncologica.